Now running for 10 years, our annual conference on
Adaptive Designs in Clinical Trials will return to London on 9th and 10th April 2018.
This year's agenda has been curated to provide you with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using
adaptive designs in their
clinical trials for successful drug, medical device and therapy development.
Giving you a fresh take on this vital area of biopharma, the event will ride the wave of technology within the pharmaceutical industry, as we consider how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously, the event will also explore how
adaptive designs are being used for the production of personalised medicines and personalised therapies.
Key Highlights
- Explore the current industry outlook and evaluate the promises and challenges of digital technology use
- Hear exciting case studies on enrichment designs and group sequential trials
- Discover how big pharma companies are using Platform Trials and self-adapting priors to advance their adaptive clinical trials
- Examine the use of adaptive clinical trials are used to produce targeted therapies
- Learn from the latest regulatory perspectives from MHRA and EMA, including planning and assessing umbrella and basket trials
Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 11th April 2018
A: Multiple hypothesis Testing in Group sequential and Adaptive Clinical TrialsWorkshop Leader: Christopher Jennison, Professor of Statistics, University of Bath
08.30 - 12.30
B: Unlocking the potential of platform trialsWorkshop Leader: Tom Parke, Director of Software Solutions, Berry Consulting
13.30 - 17.30
Speakers
- Alex Sverdlov, Director, Statistical Scientist, Novartis
- Beatrice Panico, Medical Assessor, MHRA
- Bob Clay, Managing Director, Highbury Regulatory Science
- Chris Harbron, Principal Statistical Scientist , Roche Products Ltd
- Chris Jennison, Professor of Statistics, University Of Bath
- Christine Fletcher, Executive Director Biostatistics, Amgen
- Corine Baayen, Senior Biostatistician, Lundbeck Pharma
- Daniela Casula, Biostatistician, GSK
- Frank Fleischer, Expert Statistician Methodology , Boehringer-Ingelheim
- Heiko Goette, Biostatistician, Merck & Company
- James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca
- James Wason, Group Leader, MRC Biostatistics Unit
- Loic Darchy, Head of Statistical Methodology Group, Sanofi Aventis
- Michael Proschan, Mathmatical Statistician, National Institute of Allergy and Infectious Diseases
- Olivier Collignon, Biostatistician, European Medicines Agency (EMA)
- Ros Walley, Statistician, UCB Pharma
- Sue Todd, Professor of Medical Statistics, University of Reading
- Tom Parke, Director of Software Solutions, Berry Consultants, LLP
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK
Who should attend
- Biostatisticians
- Clinical project managers
- Clinical research advisors
- Clinical Trials Directors
- Clinical scientists
- Statisticians
Venue
Copthorne Tara HotelScarsdale Place, Kensington
London, United Kingdom
